Improved glycemic control and lower frequency of severe hypoglycemia with insulin detemir; long-term experience in 105 children and adolescents with type 1 diabetes

Pediatric Diabetes

Volumn 9, Issue 4 PART 2, 2008, Pages 382-387

  Braun, Doris ^a   Konrad, Daniel ^a   Lang Muritano, Mariarosaria ^a   Schoenle, Eugen ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Detemir; Diabetes in children; Hypoglycemia; Insulin

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN DETEMIR; INSULIN GLARGINE; ISOPHANE INSULIN;

ADOLESCENT; ARTICLE; BODY MASS; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EVENING DOSAGE; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL RECORD REVIEW; OUTPATIENT DEPARTMENT; PATIENT SAFETY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SCHOOL CHILD; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; BLOOD GLUCOSE; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 48649084652     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2008.00371.x     Document Type: Article

References (23)

1. Svensson M, Eriksson JW, Dahlquist G. Early glycemic control, age at onset, and development of microvascular complications in childhood-onset type 1 diabetes: A population-based study in northern Sweden. Diabetes Care 2004: 27: 955-962.
2. Olsen BS, Sjolie A, Hougaard P et al. A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy. Danish Study Group of Diabetes in Childhood. J Diabetes Complications 2000: 14: 295-300.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993: 329: 977-986.
4. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994: 125: 177-188.
5. Danne T, Weber B, Hartmann R, Enders I, Burger W, Hovener G. Long-term glycemic control has a nonlinear association to the frequency of background retinopathy in adolescents with diabetes. Follow-up of the Berlin Retinopathy Study. Diabetes Care 1994: 17: 1390-1396.
6. Kurtzhals P, Havelund S, Jonassen I et al. Albumin binding of insulins acylated with fatty acids: Characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo. Biochem J 1995: 312: 725-731.
7. Hermansen K, Madsbad S, Perrild H, Kristensen A, Axelsen M. Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: A randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy. Diabetes Care 2001: 24: 296-301.
8. Pieber TR, Draeger E, Kristensen A, Grill V. Comparison of three multiple injection regimens for Type 1 diabetes: Morning plus dinner or bedtime administration of insulin detemir vs. morning plus bedtime NPH insulin. Diabet Med 2005: 22: 850-857.
9. Robertson KJ, Schoenle E, Gucev Z, Mordhorst L, Gall MA, Ludvigsson J. Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes. Diabet Med 2007: 24: 27-34.
10. Schoenle EJ, Schoenle D, Molinari L, Largo RH. Impaired intellectual development in children with Type I diabetes: Association with HbA(1c), age at diagnosis and sex. Diabetologia 2002: 45: 108-114.
11. Pieber TR, Treichel HC, Hompesch B et al. Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapy. Diabet Med 2007: 24: 635-642.
12. De Leeuw I, Vague P, Selam JL et al. Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin. Diabetes Obes Metab 2005: 7: 73-82.
13. Heinemann L, Sinha K, Weyer C, Loftager M, Hirschberger S, Heise T. Time-action profile of the soluble, fatty acid acylated, long-acting insulin analogue NN304. Diabet Med 1999: 16: 332-338.
14. Brunner GA, Sendhofer G, Wutte A et al. Pharmacokinetic and pharmacodynamic properties of long-acting insulin analogue NN304 in comparison to NPH insulin in humans. Exp Clin Endocrinol Diabetes 2000: 108: 100-105.
15. Danne T, Lupke K, Walte K, Von Schuetz W, Gall MA. Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children, adolescents, and adults with type 1 diabetes. Diabetes Care 2003: 26: 3087-3092.
16. Kaufman FR, Austin J, Neinstein A et al. Nocturnal hypoglycemia detected with the Continuous Glucose Monitoring System in pediatric patients with type 1 diabetes. J Pediatr 2002: 141: 625-630.
17. Kaufman FR, Austin J, Lloyd J, Halvorson M, Carpenter S, Pitukcheewanont P. Characteristics of glycemic control in young children with type 1 diabetes. Pediatr Diabetes 2002: 3: 179-183.
18. Bognetti F, Brunelli A, Meschi F, Viscardi M, Bonfanti R, Chiumello G. Frequency and correlates of severe hypoglycaemia in children and adolescents with diabetes mellitus. Eur J Pediatr 1997: 156: 589-591.
19. Mc Connell EM, Harper R, Campbell M, Nelson JK. Achieving optimal diabetic control in adolescence: The continuing enigma. Diabetes Metab Res Rev 2001: 17: 67-74.
20. Holl RW, Swift PG, Mortensen HB et al. Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: Results from the Hvidore study group. Eur J Pediatr 2003: 162: 22-29.
21. de Beaufort C, Swift PGF, Skinner CC et al. Continuing stability of center differences in pediatric diabetes care: Do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes. Diabetes Care 2007: 30: 2245-2250.
22. Hogel J, Grabert M, Sorgo W, Wudy S, Gaus W, Heinze E. Hemoglobin A1c and body mass index in children and adolescents with IDDM. An observational study from 1976-1995. Exp Clin Endocrinol Diabetes 2000: 108: 76-80.
23. Bryden KS, Neil A, Mayou RA, Peveler RC, Fairburn CG, Dunger DB. Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes. Diabetes Care 1999: 22: 1956-1960.